Join
Live feed
·
PRReleasevia Quantisnow
BioMarin Pharmaceutical Inc. logo
Inozyme Pharma Inc. logo

BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMRN (BioMarin Pharmaceutical Inc.), INZY (Inozyme Pharma Inc.) and more on Quantisnow.